Retatrutide
The most advanced weight loss treatment now available in the Philippines. Triple agonist technology for maximum results.
Clinical Trial Results
at highest dose over 48 weeks
Participants losing >15%
83%
Participants losing >20%
63%
Source: Phase 2 trial published in New England Journal of Medicine, 2023
What is Retatrutide?
Retatrutide is a next-generation weight loss medication developed by Eli Lilly. It's the first "triple agonist" that targets three different hormone receptors simultaneously:
GLP-1
Reduces appetite and slows stomach emptying
GIP
Enhances insulin response and fat metabolism
Glucagon
Increases energy expenditure and fat burning
This triple mechanism is what sets Retatrutide apart. While Tirzepatide (Mounjaro) targets two receptors and Semaglutide (Ozempic) targets one, Retatrutide's additional glucagon activity promotes greater energy expenditure—meaning your body burns more calories even at rest.
In clinical trials, this translated to the highest weight loss ever recorded in a pharmaceutical trial: participants lost an average of 24.2% of their body weight over 48 weeks.
Real Results from Real Patients
See what's possible with Retatrutide. Results vary by individual.
Before/After Photo
-18 kg
in 4 months
"Finally found something that works!"
— Maria G.
Before/After Photo
-24 kg
in 6 months
"More energy than I've had in years."
— Carlos R.
Before/After Photo
-15 kg
in 3 months
"The side effects were minimal for me."
— Ana L.
Video testimonial coming soon
"I never thought I'd see these numbers on the scale again. Retatrutide changed my life."
Patient Success Story
Lost 22kg in 5 months
* Individual results may vary. Photos and testimonials are for illustrative purposes. Always consult with a physician before starting any medication.
Frequently Asked Questions
Is Retatrutide available in the Philippines?
How is Retatrutide different from Tirzepatide or Semaglutide?
What were the clinical trial results?
Is Retatrutide FDA approved?
Who should NOT take Retatrutide?
Pricing & Dosing
Transparent pricing with everything included. No hidden fees.
| Dose | Price |
|---|---|
| R1 (1mg) Starter dose | ₱6,500 |
| R2 (2mg) Titration | ₱7,000 |
| R4 (4mg) Titration | ₱7,500 |
| R5 (5mg) Maintenance | ₱8,500 |
| R10 Multi-dose Premium pen | ₱14,000 |
| R20 Multi-dose Premium pen | ₱18,000 |
What's Included
How to Get Started
Take the Quiz
Answer questions about your health and goals (2 min)
Doctor Review
A licensed physician reviews your profile
Get Prescribed
If appropriate, your prescription is issued
Delivered
Medication shipped to your door in 3-5 days
Side Effects & Safety
Common Side Effects
- Nausea (usually temporary, 1-2 weeks)
- Constipation or diarrhea
- Decreased appetite
- Injection site reactions
Most side effects are mild and improve as your body adjusts. Starting at a low dose helps minimize them.
Serious Side Effects (Rare)
- Pancreatitis (rare)
- Gallbladder problems
- Thyroid tumors (in animal studies)
- Low blood sugar (if diabetic)
Contact your doctor immediately if you experience severe abdominal pain, vision changes, or signs of allergic reaction.
Important Safety Information
Do not use Retatrutide if you have Type 1 diabetes, a personal or family history of medullary thyroid cancer, MEN 2 syndrome, are pregnant or breastfeeding, or have a history of pancreatitis. Always disclose your full medical history to your physician.
Retatrutide vs Tirzepatide
Not sure which is right for you? Compare both options side by side.